Vázquez-Otero, Coralia
Owens, Heather N.
Arevalo, Mariana
Cui, Joyce
Chavez, Melody N.
Maconi, Melinda L.
Geiss, Carley
Turner, Kea
Vadaparampil, Susan T.
Barrios-Monroy, Veronica
Pena, Alissa
Whiting, Junmin
Christy, Shannon M. https://orcid.org/0000-0001-5306-7020
Funding for this research was provided by:
H. Lee Moffitt Cancer Center and Research Institute (Moffitt Center for Immunization and Infection Research in Cancer Award)
H. Lee Moffitt Cancer Center and Research Institute (Moffitt Merit Society Award)
Morsani College of Medicine (Research, Innovation & Scholarly Endeavors (RISE) program)
National Cancer Institute (T32CA090314)
National Cancer Institute (P30-CA076292)
Article History
Received: 18 September 2025
Accepted: 27 November 2025
First Online: 7 January 2026
Declarations
:
: This study was approved by the Moffitt Cancer Center Scientific Review Committee and the Institutional Review Board of record (Advarra) [MCC#20853; Pro00047536].
: All participants provided informed consent including having their de-identified data published in a journal article.
: Privacy rights of human subjects was observed and informed consent was obtained.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Shannon M. Christy has received investigator-initiated research funding from Merck (outside of the present work) which is being administered through H. Lee Moffitt Cancer Center and Research Institute. Dr. Christy also was an unpaid advisory member to HPV Cancers Alliance. Other authors have no conflict of interest to report.